Biolase shares are trading lower after the company announced that it will delist from the Nasdaq.
Portfolio Pulse from Benzinga Newsdesk
Biolase shares are trading lower after the company announced that it will delist from the Nasdaq.

June 18, 2024 | 8:36 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Biolase shares are experiencing a decline following the company's announcement of its delisting from the Nasdaq.
The delisting from the Nasdaq is a significant negative event for Biolase, likely leading to reduced liquidity and investor confidence, causing a short-term decline in the stock price.
CONFIDENCE 100
IMPORTANCE 90
RELEVANCE 100